• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有抗碳青霉烯类耐药感染活性的 9 元环抗菌肽。

Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant Infection.

机构信息

Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea.

Department of Internal Medicine, Division of Infectious Diseases, College of Medicine, Korea University Anam Hospital, Korea University, Seoul 02841, Korea.

出版信息

Int J Mol Sci. 2021 Nov 20;22(22):12520. doi: 10.3390/ijms222212520.

DOI:10.3390/ijms222212520
PMID:34830401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8621208/
Abstract

Carbapenem-resistant (CRAB) infection can cause acute host reactions that lead to high-fatality sepsis, making it important to develop new therapeutic options. Previously, we developed a short 9-meric peptide, Pro9-3D, with significant antibacterial and cytotoxic effects. In this study, we attempted to produce safer peptide antibiotics against CRAB by reversing the parent sequence to generate R-Pro9-3 and R-Pro9-3D. Among the tested peptides, R-Pro9-3D had the most rapid and effective antibacterial activity against Gram-negative bacteria, particularly clinical CRAB isolates. Analyses of antimicrobial mechanisms based on lipopolysaccharide (LPS)-neutralization, LPS binding, and membrane depolarization, as well as SEM ultrastructural investigations, revealed that R-Pro9-3D binds strongly to LPS and impairs the membrane integrity of CRAB by effectively permeabilizing its outer membrane. R-Pro9-3D was also less cytotoxic and had better proteolytic stability than Pro9-3D and killed biofilm forming CRAB. As an LPS-neutralizing peptide, R-Pro9-3D effectively reduced LPS-induced pro-inflammatory cytokine levels in RAW 264.7 cells. The antiseptic abilities of R-Pro9-3D were also investigated using a mouse model of CRAB-induced sepsis, which revealed that R-Pro9-3D reduced multiple organ damage and attenuated systemic infection by acting as an antibacterial and immunosuppressive agent. Thus, R-Pro9-3D displays potential as a novel antiseptic peptide for treating Gram-negative CRAB infections.

摘要

耐碳青霉烯类抗生素 (CRAB) 感染可引起急性宿主反应,导致高病死率脓毒症,因此开发新的治疗方法非常重要。先前,我们开发了一种具有显著抗菌和细胞毒性作用的短 9 肽 Pro9-3D。在这项研究中,我们试图通过反转亲本序列来生成 R-Pro9-3 和 R-Pro9-3D,从而产生针对 CRAB 的更安全的肽类抗生素。在测试的肽中,R-Pro9-3D 对革兰氏阴性菌,尤其是临床 CRAB 分离株具有最快和最有效的抗菌活性。基于脂多糖 (LPS) 中和、LPS 结合和膜去极化的抗菌机制分析以及 SEM 超微结构研究表明,R-Pro9-3D 与 LPS 强烈结合,并通过有效破坏其外膜来损害 CRAB 的膜完整性。与 Pro9-3D 相比,R-Pro9-3D 的细胞毒性更低,且具有更好的蛋白水解稳定性,并能杀死形成生物膜的 CRAB。作为一种 LPS 中和肽,R-Pro9-3D 可有效降低 LPS 诱导的 RAW 264.7 细胞中促炎细胞因子的水平。还使用 CRAB 诱导的脓毒症小鼠模型研究了 R-Pro9-3D 的防腐能力,结果表明 R-Pro9-3D 通过作为抗菌和免疫抑制剂来减少多个器官损伤并减轻全身感染。因此,R-Pro9-3D 具有作为治疗革兰氏阴性 CRAB 感染的新型防腐肽的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/409d78f98687/ijms-22-12520-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/f40d7effb8e0/ijms-22-12520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/c377164841bd/ijms-22-12520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/a5448f9763f9/ijms-22-12520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/d98363d4d331/ijms-22-12520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/c4d5281d7a43/ijms-22-12520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/91c2be09af24/ijms-22-12520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/534719301b25/ijms-22-12520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/f6831a47c9eb/ijms-22-12520-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/409d78f98687/ijms-22-12520-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/f40d7effb8e0/ijms-22-12520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/c377164841bd/ijms-22-12520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/a5448f9763f9/ijms-22-12520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/d98363d4d331/ijms-22-12520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/c4d5281d7a43/ijms-22-12520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/91c2be09af24/ijms-22-12520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/534719301b25/ijms-22-12520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/f6831a47c9eb/ijms-22-12520-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f9/8621208/409d78f98687/ijms-22-12520-g009.jpg

相似文献

1
Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant Infection.具有抗碳青霉烯类耐药感染活性的 9 元环抗菌肽。
Int J Mol Sci. 2021 Nov 20;22(22):12520. doi: 10.3390/ijms222212520.
2
A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistance.一种基于源自智利红玫瑰蜘蛛毒液的 LyeTx I 的短合成肽,具有治疗耐碳青霉烯类鲍曼不动杆菌引起的肺炎的潜力,且不会产生可检测到的耐药性。
J Antibiot (Tokyo). 2021 Jul;74(7):425-434. doi: 10.1038/s41429-021-00421-6. Epub 2021 May 10.
3
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
4
Adaptations of carbapenem resistant (CRAB) in the hospital environment causing sustained outbreak.耐碳青霉烯类肠杆菌科细菌(CRAB)在医院环境中的适应性导致持续暴发。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001345. Epub 2021 Mar 19.
5
Anti-Endotoxin 9-Meric Peptide with Therapeutic Potential for the Treatment of Endotoxemia.具有治疗内毒素血症潜力的抗内毒素九聚体肽。
J Microbiol Biotechnol. 2021 Jan 28;31(1):25-32. doi: 10.4014/jmb.2011.11011.
6
A Novel Peptide Antibiotic, Pro10-1D, Designed from Insect Defensin Shows Antibacterial and Anti-Inflammatory Activities in Sepsis Models.一种新型抗菌肽 Pro10-1D,源于昆虫防御素,在败血症模型中具有抗菌和抗炎活性。
Int J Mol Sci. 2020 Aug 27;21(17):6216. doi: 10.3390/ijms21176216.
7
Antimicrobial peptide DvAMP combats carbapenem-resistant Acinetobacter baumannii infection.抗菌肽 DvAMP 可对抗耐碳青霉烯鲍曼不动杆菌感染。
Int J Antimicrob Agents. 2024 Apr;63(4):107106. doi: 10.1016/j.ijantimicag.2024.107106. Epub 2024 Feb 6.
8
In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.盐酸氨溴索或氨氯地平与抗菌药物联合对耐碳青霉烯鲍曼不动杆菌的体外相互作用。
Lett Appl Microbiol. 2020 Mar;70(3):189-195. doi: 10.1111/lam.13259. Epub 2019 Dec 29.
9
Therapeutic Effects of Inhibitor of Expression against Carbapenem-Resistant Strains.表达抑制剂对碳青霉烯类耐药株的治疗效果。
Int J Mol Sci. 2021 Nov 12;22(22):12257. doi: 10.3390/ijms222212257.
10
Rhamnetin, a Natural Flavonoid, Ameliorates Organ Damage in a Mouse Model of Carbapenem-Resistant -Induced Sepsis.山奈酚,一种天然类黄酮,可改善耐碳青霉烯诱导脓毒症小鼠模型中的器官损伤。
Int J Mol Sci. 2022 Oct 25;23(21):12895. doi: 10.3390/ijms232112895.

引用本文的文献

1
Natural peptides and their synthetic congeners acting against through the membrane and cell wall: latest progress.作用于细胞膜和细胞壁的天然肽及其合成类似物:最新进展。
RSC Med Chem. 2024 Nov 20;16(2):561-604. doi: 10.1039/d4md00745j. eCollection 2025 Feb 19.
2
Treatment of infections caused by carbapenem-resistant .治疗耐碳青霉烯类抗生素的感染。
Front Cell Infect Microbiol. 2024 Jul 18;14:1395260. doi: 10.3389/fcimb.2024.1395260. eCollection 2024.
3
Protective Effects of Rhamnetin in Carbapenem-Resistant -Induced Sepsis Model and the Underlying Mechanism.

本文引用的文献

1
Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Infection.用于抗碳青霉烯类耐药感染联合抗菌治疗的新型肽的研发
Pharmaceutics. 2021 Oct 27;13(11):1800. doi: 10.3390/pharmaceutics13111800.
2
Antibiotic resistance and biofilm formation of Acinetobacter baumannii isolated from high-risk effluent water in tertiary hospitals in South Africa.南非三家三甲医院高危污水中分离的鲍曼不动杆菌的抗生素耐药性和生物膜形成
J Glob Antimicrob Resist. 2021 Dec;27:82-90. doi: 10.1016/j.jgar.2021.08.004. Epub 2021 Sep 1.
3
Infections in Times of COVID-19 Pandemic.
瑞香素对碳青霉烯类耐药诱导脓毒症模型的保护作用及作用机制。
Int J Mol Sci. 2023 Oct 26;24(21):15603. doi: 10.3390/ijms242115603.
4
An Update on the Therapeutic Potential of Antimicrobial Peptides against Infections.抗菌肽治疗感染的潜在疗法最新进展
Pharmaceuticals (Basel). 2023 Sep 11;16(9):1281. doi: 10.3390/ph16091281.
5
Lights and Shadows of Sepsis Management: Challenges and Future Perspectives.脓毒症管理的光明与黑暗:挑战与未来展望。
Int J Mol Sci. 2023 May 29;24(11):9426. doi: 10.3390/ijms24119426.
6
Rhamnetin, a Natural Flavonoid, Ameliorates Organ Damage in a Mouse Model of Carbapenem-Resistant -Induced Sepsis.山奈酚,一种天然类黄酮,可改善耐碳青霉烯诱导脓毒症小鼠模型中的器官损伤。
Int J Mol Sci. 2022 Oct 25;23(21):12895. doi: 10.3390/ijms232112895.
新冠疫情时期的感染情况
Pathogens. 2021 Aug 10;10(8):1006. doi: 10.3390/pathogens10081006.
4
Recent Applications of Retro-Inverso Peptides.反义倒肽的最新应用。
Int J Mol Sci. 2021 Aug 12;22(16):8677. doi: 10.3390/ijms22168677.
5
Control and management of multidrug resistant : A review of the evidence and proposal of novel approaches.多重耐药的控制与管理:证据综述及新方法建议
Infect Prev Pract. 2020 Jul 19;2(3):100077. doi: 10.1016/j.infpip.2020.100077. eCollection 2020 Sep.
6
Immune Intervention in Sepsis.脓毒症的免疫干预
Front Pharmacol. 2021 Jul 14;12:718089. doi: 10.3389/fphar.2021.718089. eCollection 2021.
7
Gram-Negative Bacteria Holding Together in a Biofilm: The Way.革兰氏阴性菌在生物膜中聚集在一起的方式
Microorganisms. 2021 Jun 22;9(7):1353. doi: 10.3390/microorganisms9071353.
8
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields.抗菌肽:生物医药与制药领域的新希望。
Front Cell Infect Microbiol. 2021 Jun 14;11:668632. doi: 10.3389/fcimb.2021.668632. eCollection 2021.
9
Antibiofilm activity of host defence peptides: complexity provides opportunities.宿主防御肽的抗生物膜活性:复杂性提供了机会。
Nat Rev Microbiol. 2021 Dec;19(12):786-797. doi: 10.1038/s41579-021-00585-w. Epub 2021 Jun 28.
10
Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development.三唑修饰的拟肽:药物发现与开发的契机。
Front Chem. 2021 May 20;9:674705. doi: 10.3389/fchem.2021.674705. eCollection 2021.